Literature DB >> 25172842

Stress signaling from human mammary epithelial cells contributes to phenotypes of mammographic density.

Rosa Anna DeFilippis1,2, Colleen Fordyce1,2, Kelley Patten1,2, Hang Chang3, Jianxin Zhao1,2, Gerald V Fontenay3, Karla Kerlikowske4,5, Bahram Parvin3, Thea D Tlsty1,2.   

Abstract

Telomere malfunction and other types of DNA damage induce an activin A-dependent stress response in mortal nontumorigenic human mammary epithelial cells that subsequently induces desmoplastic-like phenotypes in neighboring fibroblasts. Some characteristics of this fibroblast/stromal response, such as reduced adipocytes and increased extracellular matrix content, are observed not only in tumor tissues but also in disease-free breast tissues at high risk for developing cancer, especially high mammographic density tissues. We found that these phenotypes are induced by repression of the fatty acid translocase CD36, which is seen in desmoplastic and disease-free high mammographic density tissues. In this study, we show that epithelial cells from high mammographic density tissues have more DNA damage signaling, shorter telomeres, increased activin A secretion and an altered DNA damage response compared with epithelial cells from low mammographic density tissues. Strikingly, both telomere malfunction and activin A expression in epithelial cells can repress CD36 expression in adjacent fibroblasts. These results provide new insights into how high mammographic density arises and why it is associated with breast cancer risk, with implications for the definition of novel invention targets (e.g., activin A and CD36) to prevent breast cancer. ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25172842      PMCID: PMC4335659          DOI: 10.1158/0008-5472.CAN-13-3390

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  50 in total

1.  Growth factors and stromal matrix proteins associated with mammographic densities.

Authors:  Y P Guo; L J Martin; W Hanna; D Banerjee; N Miller; E Fishell; R Khokha; N F Boyd
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-03       Impact factor: 4.254

2.  Age-related lobular involution and risk of breast cancer.

Authors:  Tia R Milanese; Lynn C Hartmann; Thomas A Sellers; Marlene H Frost; Robert A Vierkant; Shaun D Maloney; V Shane Pankratz; Amy C Degnim; Celine M Vachon; Carol A Reynolds; Romayne A Thompson; L Joseph Melton; Ellen L Goode; Daniel W Visscher
Journal:  J Natl Cancer Inst       Date:  2006-11-15       Impact factor: 13.506

3.  Remodeling of the mammary microenvironment after lactation promotes breast tumor cell metastasis.

Authors:  Shauntae M McDaniel; Kristen K Rumer; Sandra L Biroc; Richard P Metz; Meenakshi Singh; Weston Porter; Pepper Schedin
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

4.  Cancer associated fibroblasts: the dark side of the coin.

Authors:  Paolo Cirri; Paola Chiarugi
Journal:  Am J Cancer Res       Date:  2011-03-12       Impact factor: 6.166

5.  Methylation of p16(INK4a) promoters occurs in vivo in histologically normal human mammary epithelia.

Authors:  Charles R Holst; Gerard J Nuovo; Manel Esteller; Karen Chew; Stephen B Baylin; James G Herman; Thea D Tlsty
Journal:  Cancer Res       Date:  2003-04-01       Impact factor: 12.701

6.  Stromal gene expression predicts clinical outcome in breast cancer.

Authors:  Greg Finak; Nicholas Bertos; Francois Pepin; Svetlana Sadekova; Margarita Souleimanova; Hong Zhao; Haiying Chen; Gulbeyaz Omeroglu; Sarkis Meterissian; Atilla Omeroglu; Michael Hallett; Morag Park
Journal:  Nat Med       Date:  2008-04-27       Impact factor: 53.440

Review 7.  The senescence-associated secretory phenotype: the dark side of tumor suppression.

Authors:  Jean-Philippe Coppé; Pierre-Yves Desprez; Ana Krtolica; Judith Campisi
Journal:  Annu Rev Pathol       Date:  2010       Impact factor: 23.472

8.  Statins upregulate CD36 expression in human monocytes, an effect strengthened when combined with PPAR-gamma ligands Putative contribution of Rho GTPases in statin-induced CD36 expression.

Authors:  Natividad Ruiz-Velasco; Angeles Domínguez; Miguel A Vega
Journal:  Biochem Pharmacol       Date:  2004-01-15       Impact factor: 5.858

9.  Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium.

Authors:  A F Olumi; G D Grossfeld; S W Hayward; P R Carroll; T D Tlsty; G R Cunha
Journal:  Cancer Res       Date:  1999-10-01       Impact factor: 12.701

10.  An optimized method for detecting gamma-H2AX in blood cells reveals a significant interindividual variation in the gamma-H2AX response among humans.

Authors:  Ismail Hassan Ismail; Tabasum Imran Wadhra; Ola Hammarsten
Journal:  Nucleic Acids Res       Date:  2007-02-06       Impact factor: 16.971

View more
  13 in total

1.  Organoid model of mammographic density displays a higher frequency of aberrant colony formations with radiation exposure.

Authors:  Qingsu Cheng; Bahram Parvin
Journal:  Bioinformatics       Date:  2020-04-01       Impact factor: 6.937

Review 2.  The Activin Social Network: Activin, Inhibin, and Follistatin in Breast Development and Cancer.

Authors:  Darcie D Seachrist; Ruth A Keri
Journal:  Endocrinology       Date:  2019-05-01       Impact factor: 4.736

3.  Overexpression of CD36 in mammary fibroblasts suppresses colony growth in breast cancer cell lines.

Authors:  Qingsu Cheng; Kosar Jabbari; Garrett Winkelmaier; Cody Andersen; Paul Yaswen; Mina Khoshdeli; Bahram Parvin
Journal:  Biochem Biophys Res Commun       Date:  2020-03-16       Impact factor: 3.575

4.  Metabolic Relationship Between Cancer-Associated Fibroblasts and Cancer Cells.

Authors:  Christos Sazeides; Anne Le
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 5.  Carcinoma-associated fibroblasts: orchestrating the composition of malignancy.

Authors:  Philippe Gascard; Thea D Tlsty
Journal:  Genes Dev       Date:  2016-05-01       Impact factor: 11.361

Review 6.  Stromal characteristics may hold the key to mammographic density: the evidence to date.

Authors:  Alastair J Ironside; J Louise Jones
Journal:  Oncotarget       Date:  2016-05-24

7.  Affinity proteomic profiling of plasma for proteins associated to area-based mammographic breast density.

Authors:  Sanna Byström; Martin Eklund; Mun-Gwan Hong; Claudia Fredolini; Mikael Eriksson; Kamila Czene; Per Hall; Jochen M Schwenk; Marike Gabrielson
Journal:  Breast Cancer Res       Date:  2018-02-14       Impact factor: 6.466

Review 8.  An overview of mammographic density and its association with breast cancer.

Authors:  Shayan Shaghayeq Nazari; Pinku Mukherjee
Journal:  Breast Cancer       Date:  2018-04-12       Impact factor: 4.239

9.  Sulindac, a Nonselective NSAID, Reduces Breast Density in Postmenopausal Women with Breast Cancer Treated with Aromatase Inhibitors.

Authors:  Patricia A Thompson; Chuan Huang; Jie Yang; Betsy C Wertheim; Denise Roe; Xiaoyue Zhang; Jie Ding; Pavani Chalasani; Christina Preece; Jessica Martinez; H-H Sherry Chow; Alison T Stopeck
Journal:  Clin Cancer Res       Date:  2021-06-10       Impact factor: 12.531

10.  Distinct phenotypes of cancer cells on tissue matrix gel.

Authors:  Kelsey F Ruud; William C Hiscox; Ilhan Yu; Roland K Chen; Weimin Li
Journal:  Breast Cancer Res       Date:  2020-07-31       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.